Neuro-inflammation and Cognitive Impairment in Alzheimer's Disease
Author Information
Author(s): Lee Jae Woong, Lee Yong Kyung, Yuk Dong Yeon, Choi Dong Young, Ban Sang Bae, Oh Ki Wan, Hong Jin Tae
Primary Institution: College of Pharmacy and CBITRC, Chungbuk National University
Hypothesis
Does neuro-inflammation induced by lipopolysaccharide (LPS) contribute to cognitive impairment through increased beta-amyloid generation?
Conclusion
The study suggests that neuro-inflammatory reactions contribute to Alzheimer's disease pathology, and that anti-inflammatory agents may help prevent the disease.
Supporting Evidence
- LPS injection caused memory impairment in mice as shown by behavioral tests.
- Repeated LPS injections led to increased levels of beta-amyloid in the brain.
- Anti-inflammatory treatment with sulindac sulfide reduced memory dysfunction and amyloid generation.
Takeaway
When mice were given a substance that causes inflammation, they had trouble remembering things because their brains made more harmful proteins. A medicine helped them remember better.
Methodology
The study used immunohistochemistry, ELISA, behavioral tests, and Western blotting to investigate the effects of LPS on memory and amyloid generation in mice.
Participant Demographics
Male ICR mice and Sprague-Dawley rats were used in the experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website